Insider Transactions Reported by 22 Insiders of Vaxcyte, Inc.

Symbol
PCVX on Nasdaq
Location
San Carlos, CA

Insiders trading volume in the past year

Vaxcyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jeff Fairman VP, Research $22,935,618 30 Dec 2022
GRANT PICKERING CHIEF EXECUTIVE OFFICER, Director $20,963,355 08 Sep 2025
Jim Wassil Chief Operating Officer $4,788,079 -$1,275,956 -21% 08 Sep 2025
ANDREW GUGGENHIME President And Cfo $4,219,640 -$1,362,923 -24% 08 Sep 2025
Mikhail Eydelman Svp, Gen Counsel & Corp Sec $3,012,039 -$804,068 -21% 05 Mar 2025
Harpreet S. Dhaliwal Chief Technical Ops Officer $1,117,174 -$454,891 -29% 31 Dec 2025
Peter Hirth Director $1,043,024 06 Jun 2024
Halley E. Gilbert Director $742,052 12 Jun 2025
Elvia Cowan Svp, Finance $666,549 -$556,972 -46% 23 Dec 2025
Heath Lukatch Director $499,264 12 Jun 2025
Michael E. Kamarck Director $364,388 13 Jun 2023
Carlos V. Paya Director $296,264 12 Jun 2025
Teri Loxam Director $296,264 -$531,963 -64% 12 Jun 2025
Anne S. Drapeau Director $296,264 12 Jun 2025
Jane Wright-Mitchell General Counsel $202,438 16 Aug 2021
Jacks Lee Director $133,139 12 Jun 2025
John Furey Director $88,189 12 Jun 2025
OLIVIER BRANDICOURT Director $33,292 12 Jun 2025
Paul Sauer SVP Process Dev, Manufacturing 30 Dec 2022
KURT VON EMSTER Director 02 Jun 2021
Patrick J. Heron Director 02 Jun 2021
Robert Lorne Hopfner Director 02 Jun 2021

Recent Insider Transactions by Companies or Individuals for Vaxcyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.